Glenview Trust Co Makes New Investment in HCA Healthcare, Inc. $HCA

Glenview Trust Co bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,267 shares of the company’s stock, valued at approximately $494,000.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. Palisade Asset Management LLC purchased a new position in HCA Healthcare during the third quarter worth about $26,000. MidFirst Bank purchased a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $28,000. Clearstead Trust LLC purchased a new stake in shares of HCA Healthcare during the second quarter valued at approximately $29,000. Cedar Mountain Advisors LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at $33,000. Finally, JPL Wealth Management LLC purchased a new position in HCA Healthcare in the third quarter valued at about $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA opened at $417.57 on Friday. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The stock has a market capitalization of $90.40 billion, a PE ratio of 13.98, a price-to-earnings-growth ratio of 1.45 and a beta of 1.10. The stock’s 50 day moving average price is $401.08 and its 200-day moving average price is $441.46.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the previous year, the company earned $6.84 earnings per share. HCA Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. Research analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analyst Ratings Changes

A number of research firms have issued reports on HCA. Morgan Stanley lowered their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. Wall Street Zen lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Robert W. Baird dropped their price target on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a research note on Monday, July 27th. The Goldman Sachs Group reduced their price target on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research report on Tuesday, July 28th. Finally, KeyCorp decreased their price target on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research note on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $462.64.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.